Protein-based pan-RAS inhibitor induces tumor regression in female mice via IFNγ and CD8+ T cell-dependent tumor necrosis.

Saved in:
Bibliographic Details
Title: Protein-based pan-RAS inhibitor induces tumor regression in female mice via IFNγ and CD8+ T cell-dependent tumor necrosis.
Authors: Nomura TK; United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, Gifu, Japan., Heishima K; Center for One Medicine Innovative Translational Research (COMIT), Gifu University, Gifu, Japan.; Institute for Advanced Study, Gifu University, Gifu, Japan., Mukai H; Department of Pharmaceutical Informatics, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan., Arai K; Department of Immune Medicine, National Cancer Center Research Institute, Tokyo, Japan., Elhelaly AE; Department of Radiology, Gifu University, Gifu, Japan.; Department of Frontier Science for Imaging, School of Medicine, Gifu University, Gifu, Japan.; Department of Food Hygiene and Control, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt., Fuchigami H; Division of Developmental Therapeutics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan., Warashina S; Department of Pharmaceutical Informatics, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan., Tahara T; Department of In vivo Imaging, Advanced Research Promoting Center, Tokushima University, Tokushima, Japan., Hyodo F; Center for One Medicine Innovative Translational Research (COMIT), Gifu University, Gifu, Japan.; Innovation Research Center for Quantum Medicine, Gifu University, Gifu, Japan.; Department of Pharmacology, School of Medicine, Gifu University, Gifu, Japan., Matsuo M; Department of Radiology, Gifu University, Gifu, Japan.; Innovation Research Center for Quantum Medicine, Gifu University, Gifu, Japan., Yasunaga M; Division of Developmental Therapeutics, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Japan., Aoki K; Department of Immune Medicine, National Cancer Center Research Institute, Tokyo, Japan., Honda R; United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, Gifu, Japan. ryohonda.rh@gmail.com.; Center for One Medicine Innovative Translational Research (COMIT), Gifu University, Gifu, Japan. ryohonda.rh@gmail.com.; Innovation Research Center for Quantum Medicine, Gifu University, Gifu, Japan. ryohonda.rh@gmail.com.
Source: Nature communications [Nat Commun] 2026 May 16; Vol. 17 (1). Date of Electronic Publication: 2026 May 16.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2041-1723
DOI:10.1038/s41467-026-73300-z